XIX International AIDS Conference


SUSA40 The Strategic Use of Antiretrovirals - Bringing HIV Prevention and Treatment Together
  Non-Commercial Satellite
Venue: Session Room 6
Time: 22.07.2012, 13:30 - 15:30
Co-Chairs: Gottfried Hirnschall, Switzerland
Nelly Mugo, Kenya
Organiser: World Health Organization, Department of HIV/AIDS, Dr. Andrew Ball, Senior Advisor Strategy, Policy and Equity
 
 
The content of recent WHO recommendations including programmatic and operational considerations shall be presented and discussed. During 2010-2011, five new prevention trials showed a positive effect and all of these employed antiretroviral agents for prevention. This had a galvanizing effect on countries, normative and implementing agencies as well as funding agencies. With the vision towards bringing HIV prevention and treatment together, WHO is releasing a roadmap towards developing a consolidated guideline by 2013 with specific rapid advice and updates being released in 2012. 1. "Guidance on couples HIV testing and counselling and treatment, and prevention for serodiscordant couples" 2. "PMTCT programmatic update" to provide guidance on the optimal choices for PMTCT regimens 3. "WHO Rapid advice on antiretroviral pre-exposure prophylaxis for MSM and serodiscordant couples for demonstration projects" The content of these recent recommendations including programmatic and operational considerations shall be presented and discussed.

13:30

Powerpoint
Welcome and Introductions to the Speakers and the Agenda


N. Mugo, Kenya
G. Hirnschall, Switzerland

13:35

Powerpoint
Opening Remarks


M. Chan, Switzerland

13:45

Powerpoint
WHO Perspectives on the Strategic Use of ARVs


A. Harries, United Kingdom

14:00

Powerpoint
Country Perspective: Malawi; Experience with PMTCT option B+: Achievements and Challenges


Z. Chirwa, Malawi

14:15

Powerpoint
Country Perspective: Cambodia; Towards Elimination of New HIV Infections and ART as Prevention.


C. Mean, Cambodia

14:30

Powerpoint
Panel on Opportunities and Priorities of ARV-based Treatment and Prevention


E. Goosby, United States
A. Binagwaho, Rwanda
W. El-Sadr, United States
G. Caswell, South Africa
T. Hallett, United Kingdom
C. Chela, Zambia

Powerpoints presentations
Welcome and Introductions to the Speakers and the Agenda -

Opening Remarks - Margaret Chan

WHO Perspectives on the Strategic Use of ARVs - Anthony Harries

Country Perspective: Malawi; Experience with PMTCT option B+: Achievements and Challenges - Zengani Chirwa

Country Perspective: Cambodia; Towards Elimination of New HIV Infections and ART as Prevention. - Chhi Vun Mean

Panel on Opportunities and Priorities of ARV-based Treatment and Prevention -



Rapporteur report

Track B report by Dr. Omar Sued


SUSA40: The Strategic Use of Antiretrovirals - Bringing HIV Prevention and Treatment Together

Sunday 22, 13:30 - 15:30

The WHO’s Director, Dr Margaret Chan reviewed the challenges of HIV fight while recognized HIV as a shrinking epidemic. Her phrase “Strong evidence support strong policies” and her passionate support of the B+ PMTCT option resulted in applaud from the public.

Dr. Harris described the process for updating the WHO ART guidelines to include the best available evidence. In 2013, WHO will release the new “Consolidated Guidelines on ARV for Treatment and Prevention of HIV”; an expanded, clinical programmatic and operational guidance.

Dr Chirwa presented the Malawian experience in integrating HIV and maternal care in 750 sites and the B+ PMTCT option. The intervention increased the access and streamlined the services, doubling the annual cases of people initiating ART in the country. Challenge remains, in particular in human resources, infrastructure, adherence and funding.

Dr. Mean described the evolution of the HIV strategy in Cambodia that resulted in 85% ART coverage in 2011. The declining of incident and prevalent cases of HIV in the last years aimed the new goal of eliminate HIV transmission in 2020 through linked responses, focus on key population, case management and immediate treatment with <500 CD4. 

A following panel, with countries representatives, partners, implementers and advocates highlighted the WHO critical role in providing guidance to the countries, called for the country responsibility and leadership and the need of be flexible to redistribute funds to higher impact interventions. Need to focus on economic development, human rights and sound science was stressed.

Dr Chan closed praising for the right balance between idealism and pragmatism. She recognized the inclusion of partners’ perspectives as an added value of WHO, signaled the notorious absence of the Global Fund in the discussion and supported the call for more transparency made by a civil society participant.




   

    The organizers reserve the right to amend the programme.


Contact Us | Site map © 2012 International AIDS Society